BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35757752)

  • 1. Serum Proteomic Analysis Identifies SAA1, FGA, SAP, and CETP as New Biomarkers for Eosinophilic Granulomatosis With Polyangiitis.
    Xiao J; Lu S; Wang X; Liang M; Dong C; Zhang X; Qiu M; Ou C; Zeng X; Lan Y; Hu L; Tan L; Peng T; Zhang Q; Long F
    Front Immunol; 2022; 13():866035. PubMed ID: 35757752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SERPINA3, FGA, AGP1, ITIH3 and SAA1 as novel biomarkers for eosinophilic granulomatosis with polyangiitis diagnosis and activity assessment.
    Liu Y; Kong X; Zhang X; Chen Z; Wang J; Chen H; Jiang L
    Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38552326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune response reflects disease activity in eosinophilic granulomatosis with polyangiitis.
    Tsurikisawa N; Oshikata C; Watanabe M; Tsuburai T; Kaneko T; Saito H
    Clin Exp Allergy; 2018 Oct; 48(10):1305-1316. PubMed ID: 29908086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible.
    Zhao B; Zheng H; Yang T; Zheng R
    Allergy Asthma Proc; 2023 Jan; 44(1):59-63. PubMed ID: 36719697
    [No Abstract]   [Full Text] [Related]  

  • 5. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
    BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Eosinophilic Granulomatosis With Polyangiitis and Associated Health Care Utilization Among Patients With Concomitant Asthma in US Commercial Claims Database.
    Gokhale M; Bell CF; Doyle S; Fairburn-Beech J; Steinfeld J; Van Dyke MK
    J Clin Rheumatol; 2021 Apr; 27(3):107-113. PubMed ID: 31693654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma.
    Pagnoux C; Nair P; Xi Y; Khalidi NA; Carette S; Cuthbertson D; Grayson PC; Koening CL; Langford CA; McAlear CA; Moreland LW; Monach PA; Seo P; Specks U; Sreih AG; Ytterberg SR; Tyrrell PN; Merkel PA;
    Clin Exp Rheumatol; 2019; 37 Suppl 117(2):40-44. PubMed ID: 30652675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
    Berti A; Volcheck GW; Cornec D; Smyth RJ; Specks U; Keogh KA
    Respir Med; 2018 Sep; 142():66-72. PubMed ID: 30170804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil extracellular traps formation in patients with eosinophilic granulomatosis with polyangiitis: association with eosinophilic inflammation.
    Natorska J; Ząbczyk M; Siudut J; Krawiec P; Mastalerz L; Undas A
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):27-32. PubMed ID: 28229830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?
    Özdemir B; Erden A; Güven SC; Armagan B; Apaydin H; Karakas Ö; Akdag AG; Ates İ; Kucuksahin O; Omma A
    Rheumatol Int; 2021 Aug; 41(8):1515-1521. PubMed ID: 34032896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic granulomatosis with polyangiitis: Cutaneous clinical and histopathologic differential diagnosis.
    Tabb ES; Duncan LM; Nazarian RM
    J Cutan Pathol; 2021 Nov; 48(11):1379-1386. PubMed ID: 34019312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Asthma Where Eosinophilic Granulomatosis with Polyangiitis Became Apparent after the Discontinuation of Dupilumab.
    Ikeda M; Ohshima N; Kawashima M; Shiina M; Kitani M; Suzukawa M
    Intern Med; 2022 Mar; 61(5):755-759. PubMed ID: 34393172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis.
    Grayson PC; Monach PA; Pagnoux C; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; Seo P; Specks U; Ytterberg SR; Merkel PA;
    Rheumatology (Oxford); 2015 Aug; 54(8):1351-9. PubMed ID: 25406357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis.
    Hashimoto T; Ueki S; Kamide Y; Miyabe Y; Fukuchi M; Yokoyama Y; Furukawa T; Azuma N; Oka N; Takeuchi H; Kanno K; Ishida-Yamamoto A; Taniguchi M; Hashiramoto A; Matsui K
    Front Immunol; 2021; 12():801897. PubMed ID: 35095884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis.
    Jakes RW; Kwon N; Nordstrom B; Goulding R; Fahrbach K; Tarpey J; Van Dyke MK
    Clin Rheumatol; 2021 Dec; 40(12):4829-4836. PubMed ID: 34159493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on eosinophilic granulomatosis with polyangiitis.
    Furuta S; Iwamoto T; Nakajima H
    Allergol Int; 2019 Oct; 68(4):430-436. PubMed ID: 31266709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.
    Groh M; Pagnoux C; Baldini C; Bel E; Bottero P; Cottin V; Dalhoff K; Dunogué B; Gross W; Holle J; Humbert M; Jayne D; Jennette JC; Lazor R; Mahr A; Merkel PA; Mouthon L; Sinico RA; Specks U; Vaglio A; Wechsler ME; Cordier JF; Guillevin L
    Eur J Intern Med; 2015 Sep; 26(7):545-53. PubMed ID: 25971154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Churg-Strauss Syndrome to Eosinophilic Granulomatosis With Polyangiitis: A Historical Review of Nomenclature and Diagnostic Criteria.
    Tabb ES; Duncan LM; Nazarian RM
    Am J Dermatopathol; 2022 May; 44(5):315-320. PubMed ID: 35427287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Cytokine Profiling Identifies Axl as a New Biomarker Candidate for Active Eosinophilic Granulomatosis With Polyangiitis.
    Ma J; Dong C; Wei S; Qiu M; Wu P; Ou C; Zhang B; Zhang X; Yan J; Zhang Q; Zhong N
    Front Mol Biosci; 2021; 8():653461. PubMed ID: 33987203
    [No Abstract]   [Full Text] [Related]  

  • 20. Eosinophilic Granulomatosis with Polyangiitis: Clinical Pathology Conference and Review.
    Wu EY; Hernandez ML; Jennette JC; Falk RJ
    J Allergy Clin Immunol Pract; 2018; 6(5):1496-1504. PubMed ID: 30197069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.